Vanguard Global Advisers
TECX

Vanguard Global Advisers’s Tectonic Therapeutic TECX Stock Holding History

Vanguard Global Advisers’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
8,765
+4,801
+121% +$141K ﹤0.01% 2332
2026
Q1 		$123K Buy
+3,964
New +$97.5K ﹤0.01% 2642

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Global Advisers's TECX Position: Q2 2026 in Review

Vanguard Global Advisers increased its Tectonic Therapeutic (TECX) stake by 121% in Q2 2026, buying an estimated $141K and bringing the position to 8,765 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

Vanguard Global Advisers first reported a position in TECX in Q1 2026 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Vanguard Global Advisers held 8,765 shares of Tectonic Therapeutic worth $301K as of Q2 2026.
  • Vanguard Global Advisers bought 4,801 Tectonic Therapeutic shares in Q2 2026, an estimated $141K.
  • Tectonic Therapeutic made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2332 holding.
  • Vanguard Global Advisers first reported a position in Tectonic Therapeutic in Q1 2026 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.